The system was used at ACV in Grand Rapids, Michigan as a comprehensive treatment solution for vascular disease & to improve patients’ QoL. The system portfolio is expected to launch in 2022 in the US & soon in Japan
The system includes the Brite Tip Radianz guiding sheath to optimize lower extremity lesion access, Saberx Radianz Pta Catheter to facilitate treatment & the S.M.A.R.T. Radianz Vascular Stent System to maintain patency for favorable outcomes
The system is intended for radial access & showed fewer vascular complications (≤1% vs 2% to 4%), 80% patient satisfaction than femoral access, 85% reduction in access site complications, 73% in major bleeding & time can be reduced from hrs. to min. with improved mobility & comfort
Ref: PRNewswire | Image: Cordis
